Journal
CURRENT PROTEIN & PEPTIDE SCIENCE
Volume 11, Issue 6, Pages 398-408Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920310791824039
Keywords
Notch; cancer; signal pathway; review; natural agents; cancer therapy; gamma-secretase inhibitors; oncogene
Categories
Funding
- National Cancer Institute, NIH [5R01CA-101870, 5R01CA131151, 5R01CA083695]
- Department of Defense [W81X-WH-08-1-0196]
- University of Texas MD Anderson Cancer Center [5P20-CA101936]
- NATIONAL CANCER INSTITUTE [R01CA083695, P20CA101936, R01CA131151, R01CA101870] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Proteins and small peptides ( growth factors and hormones) are key molecules in maintaining cellular homeostasis. To that end, Notch signaling pathway proteins are known to play critical roles in maintaining the balance between cell proliferation, differentiation and apoptosis, and thus it has been suggested that Notch may be responsible for the development and progression of human malignancies. Therefore, the Notch signaling pathway proteins may present novel therapeutic targets, which could have promising therapeutic impact on eradicating human malignancies. This review describes the role of Notch signaling pathway proteins in cancer and how its deregulation is involved in tumor development and progression leading to metastasis and the ultimate demise of patients diagnosed with cancer. Further, we summarize the role of several Notch inhibitors especially natural agents that could represent novel therapeutic strategies targeting Notch signaling toward better treatment outcome of patients diagnosed with cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available